	Three months ended,
	Sep 25, 2005			Dec 31, 2005			April 2, 2006			July 2, 2006			Oct 1, 2006
(Amounts in millions EUR)

Net system sales		459.0			456.0			553.1			840.8			856.5
Net service sales		74.2			91.8			76.3			100.9			101.9
Net sales		533.2			547.8			629.4			941.7			958.4

Cost of sales		336.0			343.7			377.8			560.8			567.5
Gross profit		197.2			204.1			251.6			380.9			390.9

Research and development costs, net of credits		80.0			82.2			87.0			92.3			100.3
Selling, general and administrative expenses		48.2			47.3			50.3			51.0			51.4
Total expenses		128.2			129.5			137.3			143.3			151.7

Operating income		69.0			74.6			114.3			237.6			239.2
Financial expense, net		(3.9	)		(1.8	)		(4.3	)		(1.9	)		(0.4	)
Income before income taxes		65.1			72.8			110.0			235.7			238.8
Provision for income taxes		(17.3	)		(21.2	)		(30.0	)		(68.6	)		(66.8	)
Net income		47.8			51.6			80.0			167.1			172.0

ASML - Quarterly Summary Ratios and other data¹

	Three months ended,
	Sep 25, 2005		Dec 31, 2005		April 2, 2006		July 2, 2006		Oct 1, 2006

Gross profit as a % of net sales		37.0		37.3		40.0		40.4		40.8
Operating income as a % of net sales		12.9		13.6		18.2		25.2		25.0
Net income as a % of net sales		9.0		9.4		12.7		17.7		17.9
Shareholders' equity as a % of total assets		46.4		45.6		47.3		42.1		45.2
Income taxes as a % of income before income taxes		26.6		29.1		27.2		29.1		28.0
Sales of new systems (units)		28		34		39		58		59
Sales of used systems (units)		11		13		12		14		12
Sales of systems total (units)		39		47		51		72		71
Backlog new systems (units)		77		86		94		114		143
Backlog used systems (units)		10		9		12		13		8
Backlog systems total (units)		87		95		106		127		151
Value of backlog new systems (EUR million)		1,216		1,411		1,560		1,785		2,099
Value of backlog used systems (EUR million)		29		23		36		45		27
Value of backlog systems total (EUR million)		1,245		1,434		1,596		1,830		2,126
Net bookings new systems (units)		38		43		47		78		88
Net bookings used systems (units)		8		12		15		15		7
Net bookings total (units)		46		55		62		93		95
Number of employees		5,014		5,055		5,088		5,209		5,388

ASML - Summary U.S. GAAP Consolidated Balance Sheets¹

	Sep 25, 2005		Dec 31, 2005			April 2, 2006		July 2, 2006		Oct 1, 2006
(Amounts in millions EUR)

ASSETS
Cash and cash equivalents		1,699.8		1,904.6			1,671.1		1,731.5		1,580.9
Accounts receivable, net		403.5		302.6			447.4		540.3		674.5
Inventories, net		653.1		777.2			940.4		916.2		837.2
Other current assets		210.7		221.4			208.0		220.7		263.8
Total current assets		2,967.1		3,205.8			3,266.9		3,408.7		3,356.4

Deferred tax asset		195.9		206.9			201.7		179.5		160.4
Other assets		45.8		39.8			38.9		38.5		36.5
Intangible assets		25.7		24.9			23.2		21.5		19.7
Property, plant and equipment		292.8		278.6			278.1		287.0		281.5
Total assets		3,527.3		3,756.0			3,808.8		3,935.2		3,854.5

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities		765.5		1,420.0	⁽⁴⁾		1,385.1		1,655.6		1,518.6
Convertible subordinated bonds		855.8		380.2	⁽⁴⁾		380.0		380.0		380.0
Long term debt and deferred liabilities		269.2		244.0			243.3		242.2		214.4
Shareholders' equity		1,636.8		1,711.8			1,800.4		1,657.4		1,741.5
Total liabilities and Shareholders' equity		3,527.3		3,756.0			3,808.8		3,935.2		3,854.5

ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows¹

	Three months ended,
	Sep 25, 2005			Dec 31, 2005			April 2, 2006			July 2, 2006			Oct 1, 2006
(Amounts in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		47.8			51.6			80.0			167.1			172.0
Depreciation and amortization		21.9			29.7			22.1			20.7			29.6
Change in tax assets and liabilities		14.2			1.4			(53.5	)		65.3			61.8
Change in assets and liabilities		89.4			126.8			(267.6	)		76.9			(261.2	)
Net cash provided (used) by operating activities		173.3			209.5			(219.0	)		330.0			2.2

CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(9.2	)		(24.0	)		(16.9	)		(14.0	)		(16.6	)
Disposals		0.4			8.8			0.7			0.7			1.3
Net cash used in investing activities		(8.8	)		(15.2	)		(16.2	)		(13.3	)		(15.3	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Redemption and/or repayment of loans		(12.1	)		(0.3	)		(0.3	)		(0.3	)		(0.3	)
Proceeds from share issuance		3.4			5.5			7.8			6.8			9.4
Cash used for share buyback		-			-			-			(252.6	)		(148.1	)
Net cash provided (used) by financing activities		(8.7	)		5.2			7.5			(246.1	)		(139.0	)
Net cash flow		155.8			199.5			(227.7	)		70.6			(152.1	)
Effect of changes in exchange rates on cash		(0.1	)		5.3			(5.8	)		(10.2	)		1.5
Net increase (decrease) in cash and cash equivalents		155.7			204.8			(233.5	)		60.4			(150.6	)

1.)	Except for balance sheet data as of December 31, 2005, all figures are unaudited.

2.)

The calculation of diluted net income per ordinary share in this period assumes conversion of ASML’s 5.50 percent Subordinated Notes due 2010 and ASML’s 5.75 percent Subordinated Notes due October 15, 2006, as such conversions would have a dilutive effect (57,388 weighted average equivalent number of ordinary shares).

3.)	The calculation of the diluted net income per ordinary shares does not assume conversion of ASML’s outstanding Convertible Subordinated Notes, as such conversions would have an anti-dilutive effect.

4.)	Since December 31, 2005 current liabilities include USD 575 million principal amount of ASML’s 5.75 percent Convertible Subordinated Notes due October 15, 2006. In previously published balance sheets, this was presented under convertible subordinated bonds.

ASML - Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. All inter-company profits, transactions and balances have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment and revenue recognition from the installation of a system upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in ASML's clean room facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system's performance is re-tested upon installation at the customer's site, ASML has never failed to successfully complete installation of a system at a customer premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of the deferred elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and over the life of the contract respectively. Revenue from extended and enhanced warranty is recognized in income on a straight-line basis over the contract period except in those circumstances in which sufficient historical evidence indicates that the costs of performing services under the contract are incurred on other than a straight-line basis. In those circumstances, revenue is recognized over the contract period in proportion to the costs expected to be incurred in performing services under the contract. The costs of providing services under extended and enhanced warranty are recognized when occurred.

Stock options

On January 1, 2006, ASML implemented the provisions of Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment” (SFAS 123(R)), using the modified prospective transition method. SFAS 123(R) requires companies to recognize the cost of employee services received (compensation costs) in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. Using the modified prospective transition method of adopting SFAS 123(R), ASML began recognizing compensation cost for equity-based awards granted, modified, repurchased, or cancelled after the required effective date of January 1, 2006. Additionally, compensation cost for the portion of equity-based awards for which the requisite service has not been rendered that are outstanding as of January 1, 2006 are also recognized as the requisite service is rendered on or after the required effective date. The compensation costs are then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.

The compensation cost for that portion of awards is based on the grant-date fair value of those awards as calculated under SFAS 123 “Accounting for Stock-Based Compensation” for pro forma disclosures.

Under the modified prospective transition method, no restatement of prior interim periods and fiscal years has been made. Prior to January 1, 2006, ASML measured compensation cost for its stock option plans using the intrinsic value method under APB 25 “Accounting for stock issued to employees” and related interpretations. As the exercise price of all stock options granted under these plans was not below the fair market price of the underlying common stock on the grant date, no compensation costs were recognized in the consolidated statements of operations.

ASML - Reconciliation U.S. GAAP - IFRS¹

Net income	Three months ended,						Nine months ended,
	Sep 25, 2005			Oct 1, 2006			Sep 25, 2005			Oct 1, 2006
(Amounts in thousands EUR)
Net income under U.S. GAAP		47,766			172,018			259,843			419,164
Share-based Payments (see Note 1)		(1,921	)		1,530			(9,631	)		1,802
Capitalization of development costs (see Note 2)		12,682			6,533			41,310			29,032
Convertible Subordinated Notes (see Note 3)		(6,957	)		(7,227	)		(16,033	)		(22,694	)
Net income under IFRS		51,570			172,854			275,489			427,304

Shareholders' Equity

	Sep 25, 2005		Dec 31, 2005		April 2, 2006		July 2, 2006		Oct 1, 2006
(Amounts in thousands EUR)
Shareholders' equity under U.S. GAAP		1,636,767		1,711,837		1,800,394		1,657,449		1,741,492
Share-based Payments (see Note 1)		2,492		2,100		2,460		2,095		5,269
Capitalization of development costs (see Note 2)		41,310		51,815		64,002		74,314		80,848
Convertible Subordinated Notes (see Note 3)		60,203		55,219		47,529		39,751		32,524
Shareholders' equity under IFRS		1,740,772		1,820,971		1,914,385		1,773,609		1,860,133

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes

Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.

Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements that are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development, ability to enforce patents, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.

	Three months ended,						Nine months ended,
	Sep 25, 2005			Oct 1, 2006			Sep 25, 2005			Oct 1, 2006
(Amounts in thousands EUR except per share data)

Net system sales		458,992			856,556			1,771,660			2,250,475
Net service sales		74,161			101,877			209,438			279,103
Net sales		533,153			958,433			1,981,098			2,529,578

Cost of sales		335,950			567,519			1,211,048			1,506,120
Gross profit		197,203			390,914			770,050			1,023,458

Research and development costs, net of credits		79,943			100,321			241,618			279,652
Selling, general and administrative expenses		48,234			51,442			153,919			152,732
Total expenses		128,177			151,763			395,537			432,384

Operating income		69,026			239,151			374,513			591,074
Financial expense, net		(3,911	)		(365	)		(12,311	)		(6,629	)

Income before income taxes		65,115			238,786			362,202			584,445
Provision for income taxes		(17,349	)		(66,768	)		(102,359	)		(165,281	)
Net income		47,766			172,018			259,843			419,164

Basic net income per ordinary share		0.10			0.37			0.54			0.88
Diluted net income per ordinary share		0.10	⁽³⁾		0.35	⁽²⁾		0.52	⁽²⁾		0.83	⁽²⁾

Number of ordinary shares used in computing per share amounts (in thousands):
Basic		484,157			460,739			483,953			474,957
Diluted		486,156	⁽³⁾		521,362	⁽²⁾		542,837	⁽²⁾		535,987	⁽²⁾

	Dec 31, 2005		Oct 1, 2006
(Amounts in thousands EUR)

ASSETS
Cash and cash equivalents		1,904,609		1,580,889
Accounts receivable, net		302,572		674,522
Inventories, net		777,200		837,216
Other current assets		221,438		263,804
Total current assets		3,205,819		3,356,431

Deferred tax asset		206,884		160,408
Other assets		39,796		36,501
Intangible assets		24,943		19,705
Property, plant and equipment		278,581		281,454
Total assets		3,756,023		3,854,499

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities		1,419,983		1,518,615
Convertible subordinated bonds		380,238		380,000
Long term debt and deferred liabilities		243,965		214,392
Shareholders' equity		1,711,837		1,741,492
Total liabilities and Shareholders' equity		3,756,023		3,854,499

	Three months ended,						Nine months ended,
	Sep 25, 2005			Oct 1, 2006			Sep 25, 2005			Oct 1, 2006
(Amounts in thousands EUR)

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		47,766			172,018			259,843			419,164
Depreciation and amortization		21,892			29,634			69,224			72,465
Change in tax assets and liabilities		14,249			61,771			96,357			73,531
Change in assets and liabilities		89,408			(261,230	)		76,554			(451,998	)
Net cash provided by operating activities		173,315			2,193			501,978			113,162

CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(9,217	)		(16,615	)		(50,026	)		(47,555	)
Disposals		426			1,376			4,441			2,742
Net cash used in investing activities		(8,791	)		(15,239	)		(45,585	)		(44,813	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Redemption and/or repayment of loans		(12,069	)		(310	)		(12,642	)		(923	)
Proceeds from share issuance		3,388			9,442			10,298			24,151
Cash used for share buyback		-			(148,146	)		-			(400,750	)
Net cash used by financing activities		(8,681	)		(139,014	)		(2,344	)		(377,522	)
Net cash flow		155,843			(152,060	)		454,049			(309,173	)
Effect of changes in exchange rates on cash		(158	)		1,482			17,584			(14,547	)
Net increase (decrease) in cash and cash equivalents		155,685			(150,578	)		471,633			(323,720	)